ALLO vs OKE · rev $22.0K vs P/E 15, rev $21.70B
Allogene Therapeutics Inc (ALLO) versus ONEOK Inc (OKE) — a side-by-side from cached financials, not a winner call.
Allogene Therapeutics Inc (ALLO) is a biotechnology company listed on US.
ONEOK Inc (OKE) is a oil & gas midstream company listed on NYSE.
Latest reported ALLO revenue for 2024-12-31 was $22.0K. Net income was -$257.6M. Revenue was down 76.8% from 2023-12-31 to 2024-12-31. ALLO currently screens at market cap $258.1M.
Latest reported OKE revenue for 2024-12-31 was $21.70B. Net income was $3.11B. Revenue was up 22.7% from 2023-12-31 to 2024-12-31. OKE currently screens at market cap $53.92B and trailing P/E 15.3.
ALLO currently screens at market cap $258.1M. OKE currently screens at market cap $53.92B and trailing P/E 15.3.
Not investment advice. Open the ALLO and OKE stock pages for the full models.
Not investment advice.